Can you provide the average price target for EXSCIENTIA PLC stock?
8 analysts have analysed EXAI and the average price target is 5.46 USD. This implies a price increase of 12.75% is expected in the next year compared to the current price of 4.84.
EXSCIENTIA PLC (EXAI) Forecast, Price Target & Analyst Ratings
NASDAQ:EXAI • US30223G1022
Current stock price
4.84 USD
+0.15 (+3.2%)
At close:
4.85 USD
+0.01 (+0.21%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for EXSCIENTIA PLC (EXAI).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- N/A
- Period
- Q3 / 2024
- EPS Estimate
- -£0.09
- Revenue Estimate
- 23.58M
Price Target Details & History
Consensus Price Target and Range
Mean target
$5.46
Upside
+ 12.75%
From current price of $4.84 to mean target of $5.46, Based on 8 analyst forecasts
Low
$5.05
Median
$5.46
High
$5.99
Price Target Revisions
1 Month
0.00%
3 Months
-10.83%
Price Target Summary
8 Wall Street analysts provided a forecast for the next 12 months for EXAI. The average price target is 5.46 USD. This implies a price increase of 12.75% is expected in the next year compared to the current price of 4.84.
The average price target has been revised downward by 10.83% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
47.50%
EXAI was analyzed by 8 analysts. The buy percentage consensus is at 48. So analysts seem to be rather neutral about EXAI.
In the previous month the buy percentage consensus was at a similar level.
EXAI was analyzed by 8 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-08-13 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2024-08-09 | TD Cowen | Downgrade | Buy -> Hold |
| 2024-07-29 | Barclays | Maintains | Overweight -> Overweight |
| 2024-07-09 | TD Cowen | Initiate | Buy |
| 2024-04-22 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-01-05 | B of A Securities | Downgrade | Buy -> Neutral |
| 2023-10-17 | Barclays | Maintains | Overweight -> Overweight |
| 2023-10-11 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-08-01 | Morgan Stanley | Reiterate | Equal-Weight -> Equal-Weight |
| 2023-07-31 | Morgan Stanley | Reiterate | Equal-Weight -> Equal-Weight |
| 2023-07-24 | Morgan Stanley | Reiterate | Equal-Weight -> Equal-Weight |
| 2023-07-21 | Berenberg | Initiate | Buy |
| 2023-07-20 | Morgan Stanley | Reiterate | Equal-Weight -> Equal-Weight |
| 2023-07-17 | Morgan Stanley | Reiterate | Equal-Weight -> Equal-Weight |
| 2023-06-26 | Morgan Stanley | Reiterate | Equal-Weight -> Equal-Weight |
| 2023-06-20 | Morgan Stanley | Reiterate | Equal-Weight |
| 2023-06-12 | Morgan Stanley | Reiterate | Equal-Weight |
| 2023-04-10 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-11-16 | Barclays | Maintains | Overweight |
| 2022-09-09 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-08-24 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-06-13 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-05-24 | Goldman Sachs | Maintains | Buy |
| 2022-04-11 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-10-26 | Goldman Sachs | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- N/A
- Period
- Q3 / 2024
- EPS Estimate
- -£0.09
- Revenue Estimate
- 23.58M
- Revenue Q2Q
- 118.33%
- EPS Q2Q
- 70.06%
- Number of Analysts
- 5
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
Full Analyst Estimates 2024 - 2026
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 37.62M 203.39% | 33.54M -10.85% | 20.079M -40.13% | 51.468M 156.33% | 36.902M -28.30% | 46.017M 24.70% | |
| EBITDA YoY % growth | -65.61M -131.35% | -194.82M -196.94% | -158.895M 18.44% | -130.127M 18.11% | -136.453M -4.86% | -96.815M 29.05% | |
| EBIT YoY % growth | -71.37M -140.06% | -206.5M -189.34% | -174.463M 15.51% | -158.161M 9.34% | -156.081M 1.32% | -153.275M 1.80% | |
| Operating Margin | -189.71% | -615.68% | -868.88% | -307.30% | -422.96% | -333.08% | |
| EPS YoY % growth | N/A | -1.40 -161.42% | -1.40 | -0.81 42.38% | -0.85 -5.54% | -0.39 54.06% |
All data in GBP
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q3 / 24 | Q4 / 24 | |
|---|---|---|
| EPS Q2Q % growth | -0.09 70.06% | -0.13 69.40% |
| Revenue Q2Q % growth | 23.58M 118.33% | 22.671M 631.32% |
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | -31.739M 21.62% | -37.568M 13.63% |
All data in GBP
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
19.83%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
13.58%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
15.52%
EBIT Next 5 Year
N/A
EXSCIENTIA PLC / EXAI Forecast FAQ
What are the consensus estimates for EXSCIENTIA PLC (EXAI) next earnings?
The consensus EPS estimate for the next earnings of EXSCIENTIA PLC (EXAI) is -0.09 USD and the consensus revenue estimate is 23.58M USD.
Can you provide the expected long term growth rate for EXSCIENTIA PLC stock?
The expected long term growth rate for EXSCIENTIA PLC (EXAI) is 13.58%.